Form 4 for ELAN Elanco Animal Health Inc
Accepted 2022-02-24 00:00:00 ET · period of report 2022-02-22 · accession 0001179110-22-001597 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-24 | 2022-02-22 | ELAN | Simmons Jeffrey N | Pres, CEO, Dir | F - Tax | $25.98 | -92.9K | 689.5K | -12% | -$2.41M | |
| 2022-02-24 | 2022-02-22 | ELAN | Simmons Jeffrey N | Pres, CEO, Dir | A - Grant | $0.00 | +229.7K | 782.4K | +42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-22 | F | D | 92,948 | $25.98 | 689,470 | D | — | — | (F2) Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan. |
| 2 | Common | Common Stock | 2022-02-22 | A | A | 229,655 | $0.00 | 782,418 | D | — | — | (F1) Vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan. |